Skip to content

Clinical trials

Neuromuscular Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromuscular Diseases Country / region: Canada Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20132
20144
20151
20162
20171
20182
20194
20201
20211
20223
20232
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Recruiting4
Active, not recruiting3
Enrolling by invitation3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fulcrum Therapeutics3
PTC Therapeutics3
PepGen Inc3
The Hospital for Sick Children3
Catabasis Pharmaceuticals2
Children's Hospital of Eastern Ontario2
Ottawa Hospital Research Institute2
Vertex Pharmaceuticals Incorporated2
Abcuro, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromuscular Diseases33
Muscular Dystrophies15
Musculoskeletal Diseases14
Nervous System Diseases12
Muscular Diseases10
Muscular Dystrophy, Duchenne9
Genetic Diseases, Inborn8
Muscular Disorders, Atrophic8
Myotonic Dystrophy5
Genetic Diseases, X-Linked4

Trials

Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.